Rare but important risks include pancreatitis, gallbladder problems, dehydration from severe vomiting/diarrhoea, and potential worsening of diabetic eye disease in people with diabetes
GLP-1RA drugs, widely used to manage diabetes and obesity, are known to slow gastrointestinal motility, potentially affecting the quality of bowel cleansing necessary for accurate colonoscopy screenings
Navigating Your Weight Loss Journey Getting Support for Your Weight Loss Journey Written on September 3, 2024 The Obesity Epidemic Obesity is a global health concern affecting more than 1 billion people
S., Christensen, S., Gianos, E., Gulati, M., Gupta, A., Horn, D., Kane, R
GLP-1RAs, originally developed for glycemic control, have shown neuroprotective properties in many preclinical studies